Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Popular depictions of schizophrenia often focus on visual ...

The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Schizophrenia might be among the most intensely studied mental ...

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...

The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...

Cobenfy Falls Short as Add-On Therapy for Schizophrenia Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a statistically ...

Schizophrenia is a mental illness that affects how you think and behave. The symptoms of schizophrenia include: Schizoid personality disorder. A person with schizoid personality disorder avoids ...

FDA approves Cobenfy, a brand new type of schizophrenia drug : Short Wave For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it ...

Schizophrenia is a complex mental health condition that affects perception, thought and emotions. This complexity is reflected in the individual manifestations of the disease: for some patients ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to ...

The chromosomal disorder 22q11.2 deletion syndrome (22q) has emerged as one of the strongest risks for schizophrenia. Scientists at St. Jude Children's Research Hospital identified malformed ...